Applicant, as named in the Orange Book

Intra-Cellular

Next listed expiry: Caplyta on 10 Dec 2040. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Caplyta · 3 strengths lumateperone tosylate	lumateperone tosylate	209500	10 Dec 2040	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.